Before starting any treatment, it's important to understand the possible risks, as well as the potential benefits. Learn about what to watch out for while taking OCREVUS and tell your …

Aug 26, 2025 · Treatment of adult patients with early primary progressive multiple sclerosis (PPMS) in terms of disease duration and level of disability, and with imaging features …

OCREVUS ZUNOVO has different dosage and administration instructions than intravenous ocrelizumab. OCREVUS ZUNOVO should be administered via subcutaneous injection by a …

Nov 13, 2024 · Ocrelizumab is used to treat both primary progressive and relapsing forms of multiple sclerosis. Includes ocrelizumab side effects, interactions, and indications.

Learn about OCREVUS ZUNOVO® (ocrelizumab and hyaluronidase-ocsq) dosing and administration. See full safety for more information.

Oct 1, 2025 · Ocrelizumab (Ocrevus) is used to treat ‘active’ relapsing MS. It’s also used to treat early primary progressive MS. Relapsing MS. You can take ocrelizumab (Ocrevus) if: You …

Jun 25, 2025 · Ocrevus (ocrelizumab) is a disease modifying drug (DMD) that is approved for relapsing remitting and for primary progressive MS. You take Ocrevus every six months, either …

Dec 9, 2025 · These highlights do not include all the information needed to use OCREVUS safely and effectively. See full prescribing information for OCREVUS. OCREVUS® (ocrelizumab) …

Jul 25, 2018 · 2 Information about ocrelizumab Marketing authorisation indication 2.1 Ocrelizumab (Ocrevus, Roche) has a marketing authorisation in the UK 'for the treatment of adult patients …

Oct 1, 2025 · Ocrelizumab injection is used to treat the relapsing forms (including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease) or …